AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer's Disease

Publisher： Karger

E-ISSN： 1660-2862|16|1-2|95-110

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.16, Iss.1-2, 2016-0, pp. : 95-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease

By  

Current Genomics, Vol. 8, Iss. 8, 2007-12 ,pp. : 509-530

Bentham Science Publishers

Access to resources Recommend Favorite

M1 Muscarinic Agonists Target Major Hallmarks of Alzheimer’s Disease – The Pivotal Role of Brain M1 Receptors

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 237-240

Karger

Access to resources Recommend Favorite

Molecular Cloning of a Novel Apoptosis-Related Gene, Human Nap1 (NCKAP1), and Its Possible Relation to Alzheimer Disease

By Suzuki T.   Nishiyama K.   Yamamoto A.   Inazawa J.   Iwaki T.   Yamada T.   Kanazawa I.   Sakaki Y.  

Genomics, Vol. 63, Iss. 2, 2000-01 ,pp. : 246-254

Elsevier

Access to resources Recommend Favorite

Employing Alzheimer Disease Animal Models for Translational Research: Focus on Dietary Components

By  

Neurodegenerative Diseases, Vol. 13, Iss. 2-3, 2013-10 ,pp. : 131-134

Karger

Access to resources Recommend Favorite

The role of caspases in Alzheimer’s disease; potential novel therapeutic opportunities

By Rohn Troy  

Apoptosis, Vol. 15, Iss. 11, 2010-11 ,pp. : 1403-1409

Springer Publishing Company

Access to resources Recommend Favorite